MARC record from Internet Archive

LEADER: 04621cam 2200709 a 4500
001 ocm32860595
003 OCoLC
005 20200522224401.0
008 950706s1994 nyua b 101 0 eng
010 $a 94069543
040 $aNLM$beng$cNLM$dAGL$dCLU$dCIN$dBAKER$dCGC$dYDXCP$dUAB$dGEBAY$dBDX$dOCLCQ$dOCLCO$dOCLCQ$dOCLCF$dOCLCO$dNLM$dOCLCO$dOCLCA
016 7 $a9506477$2DNLM
019 $a32278599
020 $a9780781702478
020 $a078170247X
035 $a(OCoLC)32860595$z(OCoLC)32278599
050 4 $aQP801.L47$bI55 1992
060 00 $aW1$bAD788 v.22 1994
060 10 $aWF 553$bI6183L 1994
070 0 $aQP801.P68A3$bv.22
072 0 $aX380
111 2 $aInternational Symposium on Trends in Eicosanoid Biology$n(2nd :$d1992 :$cInterlaken, Switzerland)
245 10 $aLeukotrienes as mediators of asthma and inflammation :$bbasic and applied research /$cSecond International Symposium on Trends in Eicosanoid Biology, Interlaken, Switzerland ; editors, Sven-Erik Dahlén [and others].
260 $aNew York :$bRaven Press,$c©1994.
300 $axv, 357 pages :$billustrations.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aAdvances in prostaglandin, thromboxane, and leukotriene research ;$vv. 22
504 $aIncludes bibliographical references and index.
505 0 $aNovel Structural and Functional Properties of Leukotriene A[subscript 4] Hydrolase: Implications for the Development of Enzyme Inhibitors / J.Z. Haeggstrom, A. Wetterholm, J.F. Medina and B. Samuelsson -- 5-Lipoxygenase Activating Protein and Leukotriene C[subscript 4] Synthase: Therapeutic Targets for Inhibiting the Leukotriene Cascade / A.W. Ford-Hutchinson -- Mode of Action of the Leukotriene Synthesis (FLAP) Inhibitor BAY X1005: Implications for Biological Regulation of 5-Lipoxygenase / A. Hatzelmann, R. Fruchtmann, K.H. Mohrs, S. Raddatz, M. Matzke, U. Pleiss, J. Keldenich and R. Muller-Peddinghaus -- Inhibition of Leukotriene Production by Inhibitors of Lipoxygenation / L.G. Garland and S.T. Hodgson -- Leukotriene Receptors and Their Selective Antagonists / P.J. Gardiner, T.S. Abram, S.R. Tudhope, N.J. Cuthbert, P. Norman and C. Brink.
520 $aThis volume presents the work of distinguished investigators who have conducted major studies on the role of eicosanoids in inflammation. The book provides an informative appraisal of the current state of the art in leukotriene and inflammation research, integrating new basic science concepts and clinical findings. The primary focus of the book is on the evidence that leukotrienes represent a group of mediators that contribute significantly to the pathobiology of asthma and play a role in other inflammatory disorders. The information presented in this volume is of vital importance to pharmacologists, biochemists, and physiologists, as well as to clinicians treating patients with asthma and other inflammatory diseases.
650 0 $aEicosanoic acid$xDerivatives$xMechanism of action$vCongresses.
650 0 $aLeukotrienes$xPhysiological effect$vCongresses.
650 0 $aAsthma$xPathophysiology$vCongresses.
650 0 $aInflammation$xMediators$vCongresses.
650 7 $aLeukotriene$2gnd
650 7 $aBronchialasthma$2gnd
650 7 $aEntzündung$2gnd
650 7 $aKongress$2gnd
650 7 $aPathobiochemie$2gnd
650 7 $aAsthma$xPathophysiology.$2fast$0(OCoLC)fst00819323
650 7 $aInflammation$xMediators.$2fast$0(OCoLC)fst00972436
650 7 $aLeukotrienes$xPhysiological effect.$2fast$0(OCoLC)fst00996940
650 12 $aAsthma$xdrug therapy.
650 12 $aLeukotrienes$xtherapeutic use.
650 22 $aInflammation$xdrug therapy.
650 22 $aLeukotrienes$xbiosynthesis.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 2 $aCongress.
700 1 $aDahlén, Sven-Erik.
776 08 $iOnline version:$aInternational Symposium on Trends in Eicosanoid Biology (2nd : 1992 : Interlaken, Switzerland).$tLeukotrienes as mediators of asthma and inflammation.$dNew York : Raven Press, ©1994$w(OCoLC)761383940
830 0 $aAdvances in prostaglandin, thromboxane, and leukotriene research ;$vv. 22.
938 $aBaker & Taylor$bBKTY$c99.00$d99.00$i078170247X$n0002585034$sactive
938 $aBrodart$bBROD$n48050237$c$99.00
938 $aYBP Library Services$bYANK$n618308
029 0 $aNLM$b9506477
029 1 $aAU@$b000011985109
029 1 $aGEBAY$b2350400
029 1 $aNLGGC$b136420036
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 83 OTHER HOLDINGS